Genetic knockout or blockage of the CGRP-RAMP1 pathway significantly inhibits tumor growth, and there is a notable increase in the infiltration of CD4+, CD8+, and NK1.1+ lymphocytes in the tumor tissue, enhancing the effectiveness of immune checkpoint inhibitors (58). Here, RAMP1 is linked to neoplasm.